Search for dissertations about: "recurrent breast cancer"
Showing result 1 - 5 of 23 swedish dissertations containing the words recurrent breast cancer.
-
1. Breast cancer : Multifocality, heterogeneity, and related genetic signatures
Abstract : Breast carcinoma often exhibits a complex subgross morphology and may occupy a large volume of the breast tissue and show unifocal, multifocal or diffuse growth patterns. Expression of estrogen- and progesterone receptors, HER2 overexpression, tumor grade, and proliferative activity allows us to classify breast carcinoma into molecular subgroups (Luminal A, Luminal B, HER2-type, triple negative, and basal-like). READ MORE
-
2. Patient-derived scaffolds as a 3D model for breast cancer
Abstract : Breast cancer is the most common cancer form in women worldwide. Many patients will have recurrent disease and more efficient targeted therapies are needed. The tumor microenvironment is a heterogenous complex mix of cells and components influencing critical cancer processes including progression, signaling and invasion. READ MORE
-
3. Molecular Analysis of Breast Cancer Transcriptomes, Genomes, and Circulating Tumor DNA
Abstract : Breast cancer is a very heterogeneous disease in terms of clinical characteristics, genetic aberrations and prognosis. In Paper I, we focused on the CD44 molecule that often is aberrantly expressed in breast cancer and is widely used as a marker for cancer stem cells. READ MORE
-
4. Wnt-5a Signalling in Human Mammary Cells: Implications for the Development of Breast Cancer
Abstract : The Wnt-5a gene encodes a secreted protein that regulates several normal processes in embryonic and adult tissues by as yet unknown mechanisms. Expression of Wnt-5a protein does not cause cell transformation, but it instead counteracts the effects induced by transforming Wnts. READ MORE
-
5. High-risk breast cancer: From biology to personalized therapeutic strategies
Abstract : Adjuvant treatment regimens for breast cancer are primarily based on patient- and tumor-related factors, e.g. patient menopausal status, tumor stage and histological grade, and the status of molecular tumor markers (HER2/neu and the estrogen receptor). READ MORE